glp-1 drugs pharmaceutical companies partnerships 2025 Drugs: Pulse Survey (U.S.) Patients Face New Barriers for

GLP-1 receptor agonists, such as semaglutide and liraglutide, are increasingly prescribed in the UK for type 2 diabetes and weight management

Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency

But outside the pharmaceutical pipeline, peptides have developed a second life within the wellness and biohacking communities

The Spirulina possess wider surface area-to-volume ratio, which sufficiently provides active sites for the adsorption of the contaminants

In: Pinaud R., Termere L., editors